Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context

Detalles Bibliográficos
Autores principales: Do, Diana V, Moini, Hadi, Wykoff, Charles C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345046/
https://www.ncbi.nlm.nih.gov/pubmed/36161828
http://dx.doi.org/10.1136/bmjophth-2022-000983
_version_ 1784761344577241088
author Do, Diana V
Moini, Hadi
Wykoff, Charles C
author_facet Do, Diana V
Moini, Hadi
Wykoff, Charles C
author_sort Do, Diana V
collection PubMed
description
format Online
Article
Text
id pubmed-9345046
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-93450462022-08-19 Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context Do, Diana V Moini, Hadi Wykoff, Charles C BMJ Open Ophthalmol Editorial BMJ Publishing Group 2022-08-01 /pmc/articles/PMC9345046/ /pubmed/36161828 http://dx.doi.org/10.1136/bmjophth-2022-000983 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Editorial
Do, Diana V
Moini, Hadi
Wykoff, Charles C
Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context
title Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context
title_full Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context
title_fullStr Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context
title_full_unstemmed Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context
title_short Frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: Protocol V results in context
title_sort frequency and timing of antivascular endothelial growth factor treatment for eyes with centre-involved diabetic macular oedema and good vision: protocol v results in context
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9345046/
https://www.ncbi.nlm.nih.gov/pubmed/36161828
http://dx.doi.org/10.1136/bmjophth-2022-000983
work_keys_str_mv AT dodianav frequencyandtimingofantivascularendothelialgrowthfactortreatmentforeyeswithcentreinvolveddiabeticmacularoedemaandgoodvisionprotocolvresultsincontext
AT moinihadi frequencyandtimingofantivascularendothelialgrowthfactortreatmentforeyeswithcentreinvolveddiabeticmacularoedemaandgoodvisionprotocolvresultsincontext
AT wykoffcharlesc frequencyandtimingofantivascularendothelialgrowthfactortreatmentforeyeswithcentreinvolveddiabeticmacularoedemaandgoodvisionprotocolvresultsincontext

Ejemplares similares